Ads
related to: teva pharmaceuticals
Search results
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded by StockNews.com to “Buy”
ETF DAILY NEWS· 3 days agoSeveral other equities research analysts have also recently commented on TEVA. JPMorgan Chase & Co. raised Teva Pharmaceutical Industries ...
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
GuruFocus.com via Yahoo Finance· 7 days agoOn May 16, 2024, Amir Weiss, the Chief Accounting Officer of Teva Pharmaceutical Industries Ltd...
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus (NYSE:...
Benzinga· 2 days agoLoading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail ...
Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune
Law.com· 2 days agoLawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 3 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) receives a Neutral rating from JP Morgan – Knox...
Knox Daily· 4 days agoIn a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million ...
Compatibility issues found with autoinjectors, FDA says
Becker’s Hospital Review· 7 days agoIf some autoinjectors are used with glatiramer acetate injections, there is an increased risk for medication errors, including a missed dose or partial administration, the agency said May 16 ...
Amphastar maintains stock target on AMP-008 FDA approval By Investing.com
Investing.com· 14 hours agoOn Thursday, Piper Sandler confirmed its Overweight rating and a $71.00 stock price target for...
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks...
Benzinga· 6 days agoPresident Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule...
JD Supra: Federal Circuit Patent Watch: District Court’s “Seemingly Siloed and Inflexible Approach”...
JD Supra· 9 hours agoProst, J. The Court affirmed the district court’s indefiniteness determination but vacated and remanded its nonobviousness determination as to the asserted patent. Regarding obviousness, the ...
